MedPath

The effect of vitamin E and C on risk factors of coronary artery disease (CAD)

Phase 3
Conditions
Coronary artery disease (CAD).
Atherosclerotic heart disease of native coronary artery
Registration Number
IRCT20180804040688N1
Lead Sponsor
Gonabad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
88
Inclusion Criteria

Inclination to participate in research
Certification of physician to receive vitamins E and C
Age 18 to 50 years old
Acceptable listening, speaking and consciousness to answer the questions
Waist circumference is more than 102 cm in men and more than 88 cm in women
Fasting triglyceride equal to or greater than 150 mg/dl
HDL less than 40 mg/dl
Systolic blood pressure equal to or greater than 135 mm Hg
Fasting glucose is greater than or equal to 110 mg/dl

Exclusion Criteria

Not pregnant
Do Not taking corticosteroids and contraceptives
Lack of underlying diseases (such as kidney and liver failure, thyroid dysfunction, malignancy, mental, autoimmune and infectious diseases)
Lack of specific medical conditions requires as a change in diet and exercise program
Lack of insulin treatment
The need for surgery during the study
Cancellation request of the patient
Incidence of unwanted side effects
Irregular consumption of supplements

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic and diastolic blood pressure. Timepoint: Before and after the intervention. Method of measurement: Mercury sphygmomanometer.;Lipid profiles. Timepoint: Before and after the intervention. Method of measurement: Laboratory instruments.;Fasting blood sugar. Timepoint: Before and after the intervention. Method of measurement: Laboratory instruments.;Body mass index (BMI). Timepoint: Before and after the intervention. Method of measurement: Weight (kilograms) / square height (meter).;C-reactive protein (CRP). Timepoint: Before and after the intervention. Method of measurement: Laboratory instruments.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath